InsidersTradesSigma
Browse the full record of transactions filed by Jones Aranthan II, Directeur des Affaires Corporatives. Officer active across 1 companies, notably Vanda Pharmaceuticals Inc.. Cumulatively, 4 disclosures have been recorded. Total volume traded: €242k. The latest transaction was disclosed on 15 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Aranthan II Jones is the Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. He is responsible for managing stakeholder relations and the company's communication strategy. His expertise contributes to optimizing performance and the organization's reputation. As a member of the management team, he plays a key role in the strategic direction of the organization's activities.